CHEK2 and breast cancer: In a 2012, a comprehensive metanalysis of 15 case-control studies conducted by Chuan Liu [24], the authors also concluded that the CHEK2 c.470T>C variant has a 1.5-fold increased risk for BC, like previous reports.